Avai Bio Inc.

NASDAQ: AVAIInvestor Site →

Avai Bio is a biotechnology company focused on advancing therapeutics solutions through innovative research and development across the life sciences sector.

Overview | Avai Bio Inc.

Company News|Latest News, Press and Market Commentary

No Newswire posts found

Bloomberg|News

▶
US Adds 29,000 Jobs in September, Jobless Rate Rises
▶
Fed Is One Bad Inflation Number Away From Hiking Rates, Dutta Says
▶
US May Send Third Carrier Strike Group to Middle East
▶
Apple wants to take over your home. Is Siri finally ready? | Power On with Mark Gurman
▶
What's Next as US Urges Europe to Release Diesel Reserves?
▶
Fed’s Kashkari on Rates, Inflation, Bond Yields, US Economy
▶
FlyDubai Incident: What We Know
▶
Breaking Down Nike's 'Disappointing' Earnings
▶
Disney's Walden Says Layoffs Are 'Extremely Painful'
▶
Why Bond Yields Are Climbing All Over the World
▶
Ben Affleck on AI and Hollywood Economics
▶
Trump Calls for Powell to Resign From Fed Board

CNBC|News

▶
Jim Cramer talks strength beneath the surface in the economy
▶
Some of the data center stocks are buying huge amounts of stock in the open markets, says Jim Cramer
▶
Brinker International CEO Kevin Hochman sits down with Jim Cramer
▶
Novo Nordisk CEO Mike Doustdar sits down with Jim Cramer
▶
Sysco CEO Kevin Hourican goes one-on-one with Jim Cramer
▶
There are no guarantees when it comes to thematic investing, says Jim Cramer
▶
Memory is the new gold, says Arista Networks CEO Jayshree Ullal
▶
ServiceNow CEO: We have a kill switch if AI agents go rogue
▶
I like data centers so much that I wish I lived in one, says Jim Cramer
▶
If you own too much tech, now is the time to use caution, says Jim Cramer
▶
I'm too worried about these trends to say IBM's now safe to buy, says Jim Cramer
▶
Boring stocks win when oil goes higher because of Iran war, says Jim Cramer

Market Chart

Spotrate

Avai Bio Inc.

ExchangeNASDAQ
SymbolNASDAQ: AVAI

Avai Bio is a biotechnology company focused on advancing therapeutics solutions through innovative research and development across the life sciences sector.

Market Summary

1

Total NASDAQ Listings: 3,500+

2

Technology Weighting: ~55%

3

Average Market Cap: $8.5B

4

Growth Bias: Innovation-led companies

Industry Insights

1

Biotech companies focus on therapeutic innovation.

2

Clinical pipelines drive valuation.

3

Regulatory milestones are key catalysts.

4

Partnerships accelerate commercialization.

Industry Leaders

Apple

AAPL

Consumer electronics and ecosystem leader.

Microsoft

MSFT

Cloud, software, and enterprise platforms.

NVIDIA

NVDA

AI and GPU computing leader.

Amazon

AMZN

E-commerce and cloud computing giant.

Meta Platforms

META

Social platforms and AI initiatives.

Alphabet

GOOGL

Search, ads, and AI infrastructure.

Tesla

TSLA

EV and AI-driven mobility platform.

Broadcom

AVGO

Semiconductors and infrastructure software.

Costco Wholesale

COST

Membership retail and consumer leader.

PepsiCo

PEP

Global food and beverage company.

Sector Stocks

Replimune Group

REPL

Oncolytic immunotherapy development.

ORIC Pharmaceuticals

ORIC

Targeted cancer therapies.

Anixa Biosciences

ANIX

Cancer immunotherapy and vaccines.

ImmunityBio

IBRX

Cell-based immunotherapy platform.

Iovance Biotherapeutics

IOVA

Tumor-infiltrating lymphocyte therapies.

Precigen

PGEN

Gene and cell therapy platform.

Exelixis

EXEL

Cancer-focused biotech therapeutics.

Incyte

INCY

Oncology and inflammation treatments.

BridgeBio Pharma

BBIO

Genetic disease therapeutics.

Krystal Biotech

KRYS

Gene therapy innovation.

Kymera Therapeutics

KYMR

Targeted protein degradation platform.

Moderna

MRNA

mRNA-based therapeutics and vaccines.

Regeneron Pharmaceuticals

REGN

Biologic drug development leader.

Vertex Pharmaceuticals

VRTX

Genetic disease therapies.

BioMarin Pharmaceutical

BMRN

Rare disease treatments.

Alnylam Pharmaceuticals

ALNY

RNA interference therapeutics.

Trading Platforms